08/12/2020
Global equitable access to vaccines in low- and lower-middle-income countries has been estimated to generate economic benefits of at least US$ 153bn in 2020–21, and US$ 466bn by 2025, in 10 major economies (Canada, France, Germany, Japan, Qatar, South Korea, Sweden, UAE, UK and USA), according to Eurasia Group's new report commissioned by the Bill & Melinda Gates Foundation.
This is more than 12 times the US$ 38bn estimated total cost of the Access to COVID-19 Tools (ACT) Accelerator, led by WHO, and aiming to support the development and equitable distribution of the tests, treatments and vaccines the world needs to fight COVID-19.
Read more: https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21